Article
Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival.
International journal of molecular sciences - 8 May 2023
Sayagués José María, Montero Juan Carlos, Jiménez-Pérez Andrea, Del Carmen Sofía, Rodríguez Marta, Vidal Tocino Rosario, Montero Enrique, Sanz Julia, Abad Mar
Abstract excerpt
Sporadic colorectal cancer (sCRC) initially presents as metastatic tumors in 25-30% of patients. The 5-year overall survival (OS) in patients with metastatic sCRC is 50%, falling to 10% in patients presenting with synchronous metastatic disease (stage IV). In this study, we systematically analyzed the mutations of RAS, PIK3CA and BRAF genes in circulating tumor DNA (ctDNA) and tumoral tissue DNA (ttDNA) from 51...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
